C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Brodalumab (Siliq™) |
02/15/2018 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Dupilumab (Dupixent®) |
02/15/2018 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Praluent (alirocumab) |
11/15/2015 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Exenatide, (Bydureon - extended-release formulation) |
02/23/2014 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Liraglutide (Saxenda®, Victoza®) |
05/16/2024 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Pramlintide (Symlin) |
09/07/2013 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Tesamorelin (Egrifta®) |
09/07/2013 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Asfotase-alfa (Strensiq™) |
02/15/2016 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Anakinra (Kineret®) |
09/07/2013 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Exenatide (Byetta) |
09/07/2013 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Golimumab (Simponi®) |
09/07/2013 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Peginterferon alfa-2b (Pegintron) |
09/07/2013 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Pegvisomant (Somavert®) |
09/07/2013 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Tanzeum (albiglutide) |
09/15/2014 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Parathyroid hormone (Natpara®) |
04/26/2015 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Secukinumab (Cosentyx™) subcutaneous use* |
04/26/2015 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Liraglutide (Saxenda®) |
05/16/2024 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
All insulin products |
11/19/2022 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Dulaglutide (Trulicity™) |
08/15/2015 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Methotrexate (Otrexup™) |
08/15/2015 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Evolocumab (Repatha™) |
01/15/2016 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Peginterferon beta-1a (Plegridy™) |
06/15/2016 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Ixekizumab (Taltz™) |
07/15/2016 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Etanercept-SZZS (Erelzi™) |
11/15/2016 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Adalimumab-atto (Amjevita™) |
12/15/2016 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Metreleptin (Myalept®) |
01/15/2017 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Mipomersen Sodium (Kynamro®) |
01/15/2017 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Adalimumab-adbm (Cyltezo®) |
12/01/2019 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Galcanezumab-gnlm (Emgality®) |
12/01/2019 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Erenumab-aooe (Aimovig®) |
12/01/2019 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Semaglutide (Ozempic®, Wegovy®) |
05/16/2024 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Sarilumab (Kevzara®) |
12/01/2019 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Abaloparatide (Tymlos™) |
12/01/2019 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Abatacept (Orencia®) |
12/01/2019 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Pasireotide (Signifor®) |
04/05/2021 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Somapacitan-beco (Sogroya®) |
04/05/2021 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Peginterferon Alfa-2a (Pegasys®) |
10/15/2021 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Ropeginterferon alfa-2b-njft (Besremi®) |
04/24/2022 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Risankizumab-rzaa (Skyrizi™) subcutaneous use* |
05/15/2022 |
N/A |
Acceptable Evidentiary Criteria Available |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Ofatumumab (Kesimpta®) |
07/10/2022 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Tralokinumab-Idrm (Adbry™) |
11/01/2022 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Tirzepatide (Mounjaro™, Zepbound™) |
05/16/2024 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Adalimumab-bwwd (Hadlima), Adalimumab-fkjp (Hulio®), Adalimumab-adaz (Hyrimoz), Adalimumab-aqvh (Yusimry)
|
07/01/2023 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Vedolizumab (Entyvio®) subcutaneous use* |
01/14/2024 |
N/A |
Apparent on its Face |
C9399 |
UNCLASSIFIED DRUGS OR BIOLOGICALS |
Adalimumab-aaty (Yuflyma) |
01/14/2024 |
N/A |
Apparent on its Face |
J0129 |
INJECTION, ABATACEPT, 10 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED) |
Orencia®, subcutaneous use* |
04/05/2021 |
N/A |
Apparent on its Face |
J0135 |
INJECTION, ADALIMUMAB, 20 MG |
Humira® |
09/07/2013 |
N/A |
Apparent on its Face |
J0270 |
INJECTION, ALPROSTADIL, 1.25 MCG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED) |
Prostaglandin E1 |
09/07/2013 |
N/A |
Apparent on its Face |
J0364 |
INJECTION, APOMORPHINE HYDROCHLORIDE, 1 MG |
Apokyn® |
09/07/2013 |
N/A |
Apparent on its Face |
J0593 |
INJECTION, LANADELUMAB-FLYO, 1 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF-ADMINISTERED) |
Takhzyro™ |
12/01/2019 |
N/A |
Apparent on its Face |
J0599 |
INJECTION, C-1 ESTERASE INHIBITOR (HUMAN), (HAEGARDA), 10 UNITS |
Haegarda® |
01/01/2019 |
N/A |
Apparent on its Face |
J0630 |
INJECTION, CALCITONIN SALMON, UP TO 400 UNITS |
Calcimar, Calcitonin-salmon, Miacalcin |
09/07/2013 |
N/A |
Apparent on its Face |
J0801 |
INJECTION, CORTICOTROPIN (ACTHAR GEL), UP TO 40 UNITS |
H.P. Acthar® Gel subcutaneous use** |
10/01/2023 |
N/A |
Apparent on its Face |
J0802 |
INJECTION, CORTICOTROPIN (ANI), UP TO 40 UNITS |
Purified Cortrophin Gel® manufactured by ANI subcutaneous use** |
10/01/2023 |
N/A |
Apparent on its Face |
J1324 |
INJECTION, ENFUVIRTIDE, 1 MG |
Fuzeon® |
09/07/2013 |
N/A |
Apparent on its Face |
J1438 |
INJECTION, ETANERCEPT, 25 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED) |
Enbrel® |
09/07/2013 |
N/A |
Apparent on its Face |
J1562 |
INJECTION, IMMUNE GLOBULIN (VIVAGLOBIN), 100 MG |
Vivaglobulin |
09/07/2013 |
N/A |
Apparent on its Face |
J1595 |
INJECTION, GLATIRAMER ACETATE, 20 MG |
Copaxone® |
09/07/2013 |
N/A |
Apparent on its Face |
J1628 |
INJECTION, GUSELKUMAB, 1 MG |
Tremfya® |
05/15/2021 |
N/A |
Acceptable Evidentiary Criteria Available |
J1675 |
INJECTION, HISTRELIN ACETATE, 10 MICROGRAMS |
N/A |
09/07/2013 |
N/A |
Apparent on its Face |
J1744 |
INJECTION, ICATIBANT, 1 MG |
Firazyr® |
09/07/2013 |
N/A |
Apparent on its Face |
J1748 |
INJECTION, INFLIXIMAB-DYYB (ZYMFENTRA), 10 MG |
Infliximab-dyyb (Zymfentra™) |
08/18/2024 |
N/A |
Apparent on its Face |
J1811 |
INSULIN (FIASP) FOR ADMINISTRATION THROUGH DME (I.E., INSULIN PUMP) PER 50 UNITS |
Fiasp® |
07/01/2023 |
N/A |
Apparent on its Face |
J1812 |
INSULIN (FIASP), PER 5 UNITS |
Fiasp® |
07/01/2023 |
N/A |
Apparent on its Face |
J1813 |
INSULIN (LYUMJEV) FOR ADMINISTRATION THROUGH DME (I.E., INSULIN PUMP) PER 50 UNITS |
Lyumjev® |
07/01/2023 |
N/A |
Apparent on its Face |
J1814 |
INSULIN (LYUMJEV), PER 5 UNITS |
Lyumjev®
100 IU* |
07/01/2023 |
N/A |
Apparent on its Face |
J1814 |
INSULIN (LYUMJEV), PER 5 UNITS |
Lyumjev®
200 IU
|
07/01/2023 |
N/A |
Apparent on its Face |
J1815 |
INJECTION, INSULIN, PER 5 UNITS |
All insulin products |
11/19/2022 |
N/A |
Apparent on its Face |
J1817 |
INSULIN FOR ADMINISTRATION THROUGH DME (I.E., INSULIN PUMP) PER 50 UNITS |
All insulin products |
11/19/2022 |
N/A |
Apparent on its Face |
J1826 |
INJECTION, INTERFERON BETA-1A, 30 MCG |
Avonex Pen®, Rebif®, Rebif® Rebidose® |
09/01/2021 |
N/A |
Apparent on its Face |
J1830 |
INJECTION, INTERFERON BETA-1B, 0.25 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED) |
Betaseron® |
09/07/2013 |
N/A |
Apparent on its Face |
J1941 |
INJECTION, FUROSEMIDE (FUROSCIX), 20 MG |
Furoscix® |
08/20/2023 |
N/A |
Apparent on its Face |
J2170 |
INJECTION, MECASERMIN, 1 MG |
Increlex |
09/07/2013 |
N/A |
Apparent on its Face |
J2212 |
INJECTION, METHYLNALTREXONE, 0.1 MG |
Relistor |
09/07/2013 |
N/A |
Apparent on its Face |
J2267 |
INJECTION, MIRIKIZUMAB-MRKZ, 1 MG |
Mirikizumab-mrkz (Omvoh™) subcutaneous use* |
07/18/2024 |
N/A |
Apparent on its Face |
J2354 |
INJECTION, OCTREOTIDE, NON-DEPOT FORM FOR SUBCUTANEOUS OR INTRAVENOUS INJECTION, 25 MCG |
Sandostatin LAR Depot, subcutaneous use* |
09/07/2013 |
N/A |
Apparent on its Face |
J2440 |
INJECTION, PAPAVERINE HCL, UP TO 60 MG |
N/A |
09/07/2013 |
N/A |
Apparent on its Face |
J2760 |
INJECTION, PHENTOLAMINE MESYLATE, UP TO 5 MG |
Regitine |
09/07/2013 |
N/A |
Apparent on its Face |
J2940 |
INJECTION, SOMATREM, 1 MG |
N/A |
09/07/2013 |
N/A |
Apparent on its Face |
J2941 |
INJECTION, SOMATROPIN, 1 MG |
Genotropin, Humatrope, Nutropin, Omnitrope, Saizen, Serostim, Zorbtive |
09/07/2013 |
N/A |
Apparent on its Face |
J3030 |
INJECTION, SUMATRIPTAN SUCCINATE, 6 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF ADMINISTERED) |
Imitrex, Sumavel Dosepro |
09/07/2013 |
N/A |
Apparent on its Face |
J3031 |
INJECTION, FREMANEZUMAB-VFRM, 1 MG (CODE MAY BE USED FOR MEDICARE WHEN DRUG ADMINISTERED UNDER THE DIRECT SUPERVISION OF A PHYSICIAN, NOT FOR USE WHEN DRUG IS SELF-ADMINISTERED) |
Ajovy™ |
12/01/2019 |
N/A |
Apparent on its Face |
J3110 |
INJECTION, TERIPARATIDE, 10 MCG |
Forteo® |
09/07/2013 |
N/A |
Apparent on its Face |
J3355 |
INJECTION, UROFOLLITROPIN, 75 IU |
Bravelle®, Metrodin® |
09/07/2013 |
N/A |
Apparent on its Face |
J3357 |
USTEKINUMAB, FOR SUBCUTANEOUS INJECTION, 1 MG |
Stelara® |
10/15/2021 |
N/A |
Acceptable Evidentiary Criteria Available |
J3490 |
UNCLASSIFIED DRUGS |
Pasireotide (Signifor®) |
04/05/2021 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Exenatide, (Bydureon - extended-release formulation) |
02/23/2014 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Liraglutide (Saxenda®, Victoza®) |
05/16/2024 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Pramlintide (Symlin) |
09/07/2013 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Tesamorelin (Egrifta®) |
09/07/2013 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Tanzeum (albiglutide) |
09/15/2014 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Praluent (alirocumab) |
11/15/2015 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Adalimumab-adbm (Cyltezo®) |
12/01/2019 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
All insulin products |
11/19/2022 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Somapacitan-beco (Sogroya®) |
04/05/2021 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Peginterferon Alfa-2a (Pegasys®) |
10/15/2021 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Ropeginterferon alfa-2b-njft (Besremi®) |
04/24/2022 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Risankizumab-rzaa (Skyrizi™) subcutaneous use* |
05/15/2022 |
N/A |
Acceptable Evidentiary Criteria Available |
J3490 |
UNCLASSIFIED DRUGS |
Ofatumumab (Kesimpta®) |
07/10/2022 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Tralokinumab-Idrm (Adbry™) |
11/01/2022 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Tirzepatide (Mounjaro™, Zepbound™) |
05/16/2024 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Adalimumab-bwwd (Hadlima),
Adalimumab-fkjp (Hulio®), Adalimumab-adaz (Hyrimoz), Adalimumab-aqvh (Yusimry)
|
07/01/2023 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Adalimumab-aaty (Yuflyma) |
01/14/2024 |
N/A |
Apparent on its Face |
J3490 |
UNCLASSIFIED DRUGS |
Vedolizumab (Entyvio®) subcutaneous use* |
01/14/2024 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Vedolizumab (Entyvio®) subcutaneous use* |
01/14/2024 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Adalimumab-aaty (Yuflyma) |
01/14/2024 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Adalimumab-bwwd (Hadlima), Adalimumab-fkjp (Hulio®), Adalimumab-adaz (Hyrimoz), Adalimumab-aqvh (Yusimry)
|
07/01/2023 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Tirzepatide (Mounjaro™,Zepbound™) |
05/16/2024 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Tralokinumab-Idrm (Adbry™) |
11/01/2022 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Ofatumumab (Kesimpta®) |
07/10/2022 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Risankizumab-rzaa (Skyrizi™) subcutaneous use* |
05/15/2022 |
N/A |
Acceptable Evidentiary Criteria Available |
J3590 |
UNCLASSIFIED BIOLOGICS |
Ropeginterferon alfa-2b-njft (Besremi®) |
04/24/2022 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Peginterferon Alfa-2a (Pegasys®) |
10/15/2021 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Somapacitan-beco (Sogroya®) |
04/05/2021 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Galcanezumab-gnlm (Emgality®) |
12/01/2019 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Abaloparatide (Tymlos™) |
12/01/2019 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Sarilumab (Kevzara®) |
12/01/2019 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Semaglutide (Ozempic®, Wegovy®) |
05/16/2024 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Erenumab-aooe (Aimovig®) |
12/01/2019 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Abatacept (Orencia®) |
12/01/2019 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Parathyroid hormone (Natpara®) |
04/26/2015 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Secukinumab (Cosentyx™) subcutaneous use* |
04/26/2015 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Liraglutide (Saxenda®,Victoza®) |
06/15/2015 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
All insulin products |
11/19/2022 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Dulaglutide (Trulicity™) |
08/15/2015 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Methotrexate (Otrexup™) |
08/15/2015 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Exenatide (Byetta) |
09/07/2013 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Golimumab (Simponi®) |
09/07/2013 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Peginterferon alfa-2b (Pegintron) |
09/07/2013 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Pegvisomant (Somavert®) |
09/07/2013 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Evolocumab (Repatha™) |
01/15/2016 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Asfotase-alfa (Strensiq™) |
02/15/2016 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Peginterferon beta-1a (Plegridy™) |
06/15/2016 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Ixekizumab (Taltz™) |
07/15/2016 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Anakinra (Kineret®) |
09/07/2013 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Etanercept-SZZS (Erelzi™) |
11/15/2016 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Adalimumab-atto (Amjevita™) |
12/15/2016 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Mipomersen Sodium (Kynamro®) |
01/15/2017 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Metreleptin (Myalept®) |
01/15/2017 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Brodalumab (Siliq™) |
02/15/2018 |
N/A |
Apparent on its Face |
J3590 |
UNCLASSIFIED BIOLOGICS |
Dupilumab (Dupixent®) |
02/15/2018 |
N/A |
Apparent on its Face |
J7999 |
COMPOUNDED DRUG, NOT OTHERWISE CLASSIFIED |
TriMix |
09/07/2013 |
N/A |
Apparent on its Face |
J7999 |
COMPOUNDED DRUG, NOT OTHERWISE CLASSIFIED |
Quad-Mix |
03/17/2017 |
N/A |
Apparent on its Face |
J9212 |
INJECTION, INTERFERON ALFACON-1, RECOMBINANT, 1 MICROGRAM |
Infergen® |
09/07/2013 |
N/A |
Apparent on its Face |
J9213 |
INJECTION, INTERFERON, ALFA-2A, RECOMBINANT, 3 MILLION UNITS |
Roferon®-A |
09/07/2013 |
N/A |
Apparent on its Face |
J9216 |
INJECTION, INTERFERON, GAMMA 1-B, 3 MILLION UNITS |
Actimmune® |
09/07/2013 |
N/A |
Apparent on its Face |
J9218 |
LEUPROLIDE ACETATE, PER 1 MG |
Lupron |
09/07/2013 |
N/A |
Apparent on its Face |
Q0515 |
INJECTION, SERMORELIN ACETATE, 1 MICROGRAM |
Geref Diagnostic |
09/07/2013 |
N/A |
Apparent on its Face |
Q3027 |
INJECTION, INTERFERON BETA-1A, 1 MCG FOR INTRAMUSCULAR USE |
Avonex® |
09/01/2021 |
N/A |
Apparent on its Face |
Q3028 |
INJECTION, INTERFERON BETA-1A, 1 MCG FOR SUBCUTANEOUS USE |
Rebif® |
09/01/2021 |
N/A |
Apparent on its Face |
Q5131 |
INJECTION, ADALIMUMAB-AACF (IDACIO), BIOSIMILAR, 20 MG |
Idacio® |
07/01/2023 |
N/A |
Apparent on its Face |
Q5132 |
INJECTION, ADALIMUMAB-AFZB (ABRILADA), BIOSIMILAR, 10 MG |
Abrilada™ |
07/01/2023 |
N/A |
Apparent on its Face |
Q5137 |
INJECTION, USTEKINUMAB-AUUB (WEZLANA), BIOSIMILAR, SUBCUTANEOUS, 1 MG |
Ustekinumab-auub (Wezlana™) |
07/04/2024 |
N/A |
Apparent on its Face |